It's the first tubeless system with smartphone control.
Nearly 80% of the 30 million diabetics in the U.S. still manage their insulin by what’s known as the multiple daily injection (MDI) method.
The Dow Jones Industrial Average traded down to 12,367.72 then approached 12,500 going into the final half hour of trading. The NASDAQ traded down to 2774.76 then approached 2850 going into the
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.
Website: | www.insulet.com |
Email: | dgordon@insulet.com |
Main Phone: | +1 978 600-7000 |
Address: | 100 Nagog Park |
Address 2: | Suite 200 |
State: | MA |
City / Town: | Acton |
Country: | US |
Postal Code: | 01720 |
Exchange: | NGS |
CEO: | Shacey Petrovic |
Employees: | 1900 |
NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
It's the first tubeless system with smartphone control.
Nearly 80% of the 30 million diabetics in the U.S. still manage their insulin by what’s known as the multiple daily injection (MDI) method.
The Dow Jones Industrial Average traded down to 12,367.72 then approached 12,500 going into the final half hour of trading. The NASDAQ traded down to 2774.76 then approached 2850 going into the
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |